Loading quotes...
Forecast
There is no analyst data available for this company.
News Go to news feed
Applied Nutrition raises full-year guidance, shares climb around 5%
Applied Nutrition expects revenue of about £160m for fiscal 2026 (+≈50%) and adjusted EBITDA of around £43.3m (+≈40%), both metrics above consensus. The shares jumped 5.15% to 338.05 pence and are trading near the 52-week high. The company signals a stronger-growth 2027 and is expanding production in North America, including by acquiring assets of the Nutrablend Group and through new licensing and commercial partnerships. Partnerships with retailers such as Holland & Barrett and new US listings are expected to support further revenue growth. » More on de.investing.com
Applied Nutrition expects 2026 results about 10% above market expectations
Applied Nutrition said financial results for the year ending 31 July 2026 are expected to be about 10% above the current market consensus. The company attributes this to continued momentum and a strong order book and expects a particularly strong first half in the main season for health, fitness and well‑being. Before the announcement, consensus expectations were revenue of £122.3m and adjusted EBITDA of £34.4m. » More on de.investing.com
Financials
| (EUR) | Jan 2026 | |
|---|---|---|
| Revenue | 86.05M | - |
| Gross profit | 39.27M | - |
| Net profit | 17.79M | - |
| EBITDA | 24.83M | - |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €927.33M |
Number of shares | 250M |
52-week high/low | €4.16 - €1.85 |
| Dividends | No |
Beta | 1.62 |
P/E ratio | 28.76 |
PEG ratio | 0.29 |
P/B ratio | 11.40 |
P/S ratio | 5.92 |
Company profile
| Name | Applied Nutrition PLC |
| CEO | Thomas Michael Ryder |
| Employees | 270 |
Discover assets
Shareholders of Applied Nutrition PLC also invest in the following assets
